Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
44.55
-0.04 (-0.09%)
At close: Feb 13, 2026, 4:00 PM EST
45.30
+0.75 (1.68%)
After-hours: Feb 13, 2026, 7:56 PM EST
Medline Stock Forecast
Stock Price Forecast
The 23 analysts that cover Medline stock have a consensus rating of "Strong Buy" and an average price target of $47.74, which forecasts a 7.16% increase in the stock price over the next year. The lowest target is $40 and the highest is $55.
Price Target: $47.74 (+7.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Medline stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 |
|---|---|
| Strong Buy | 8 |
| Buy | 12 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Tigress Financial | Tigress Financial | Strong Buy Initiates $55 | Strong Buy | Initiates | $55 | +23.46% | Feb 5, 2026 |
| Citigroup | Citigroup | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +7.74% | Jan 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $50 | Buy | Initiates | $50 | +12.23% | Jan 12, 2026 |
| Stifel | Stifel | Strong Buy Initiates $46 | Strong Buy | Initiates | $46 | +3.25% | Jan 12, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $49 | Strong Buy | Initiates | $49 | +9.99% | Jan 12, 2026 |
Financial Forecast
Revenue This Year
28.72B
from 25.51B
Increased by 12.59%
Revenue Next Year
31.17B
from 28.72B
Increased by 8.52%
EPS This Year
1.22
from 0.07
Increased by 1,676.12%
EPS Next Year
1.50
from 1.22
Increased by 22.58%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 29.6B | 32.5B | |
| Avg | 28.7B | 31.2B | |
| Low | 27.4B | 29.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 16.1% | 13.3% | |
| Avg | 12.6% | 8.5% | |
| Low | 7.5% | 2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.40 | 1.60 | |
| Avg | 1.22 | 1.50 | |
| Low | 0.99 | 1.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,932.8% | 30.8% | |
| Avg | 1,676.1% | 22.6% | |
| Low | 1,345.0% | -2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.